Inhibitory effect of anti-epidermal growth factor receptor antibody on a human gastric cancer

Cancer

Volumn 77, Issue 8 SUPPL., 1996, Pages 1639-1645

  Teramoto, Tadashi ^a   Onda, Masahiko ^a   Tokunaga, Akira ^a   Asano, Goro ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

anti EGF receptor antibody; EGF receptor; epidermal growth factor (EGF); human gastric cancer; transforming growth factor alpha

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; RECEPTOR ANTIBODY; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; AVIAN ERYTHROBLASTOSIS ONCOVIRUS; CANCER CONTROL; CELL CULTURE; CONFERENCE PAPER; DISEASE ASSOCIATION; LYMPH NODE METASTASIS; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL DIVISION; EPIDERMAL GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; IODINE RADIOISOTOPES; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; RADIOLIGAND ASSAY; RECEPTOR, EPIDERMAL GROWTH FACTOR; STOMACH NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0029947326     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960415)77:8<1639::AID-CNCR33>3.0.CO;2-Z     Document Type: Conference Paper

References (29)

1. Downward J, Yarden Y, Mayer E, Scrace G, Totty N, Stockwell P, et al. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 1984;307:521-7.
2. Carpenter G, Cohen S. Epidermal growth factor. Ann Rev Biochem 1979;48:193-216.
3. Salomon DS, Kim N, Saeki T, Ciardiello F. Transforming growth factor-α: an oncodevelopmental growth factor. Cancer Cells 1990;2:389-97.
4. Mendelsohn J, Gabrilove J. Growth factors in malignancy. In: Mendelsohn J, Howley PM, Israel M, Liotta L, editors. The molecular basis of cancer. Philadelphia: W. B. Saunders Company, 1995:432-59.
5. Ozawa S, Ueda M, Ando N, Shimizu N, Abe O. Prognostic significance of epidermal growth factor receptor in esophageal squamous cell carcinomas. Cancer 1989;63:2169-73.
6. 2) and epidermal growth factor (EGF) in gastric cancer as biological markers of proliferation and progression. J Jpn Surg Soc 1987;88:1113-6.
7. Onda M, Tokunaga A, Nishi K, Yoshiyuki T, Shimizu Y, Kiyama T, et al. The correlation of epidermal growth factor with invasion and metastasis in human gastric cancer. Jpn J Surg 1990;20:269-74.
8. Yasui W, Hata J, Yokozaki H, Nakatani H, Ochiai A, Itoh H, et al. Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma. Int J Cancer 1988;41:211-7.
9. Yonemura Y, Takamura H, Ninomiya I, Fushida S, Tsugawa K, Kaji M, et al. Interrelationship between transforming growth factor-alpha and epidermal growth factor receptor in advanced gastric cancer. Oncology 1992;49:157-61.
10. Kiyama T, Onda M, Tokunaga A, Fujita I, Okuda T, Mizutani T, et al. Correlation between epidermal growth factor receptor concentration and the growth of human gastric cancer xenografts in nude mice. Gastroenterol Jpn 1992;27:459-65.
11. Okuda T, Onda M, Tokunaga A, Sugisaki Y. Stimulatory effect of EGF and inhibitory effect of sialoadenectomy on growth of an EGF receptor-hyperproducing human gastric cancer xenograft in nude mice. Surg Today 1994;24:725-33.
12. Tokunaga A, Onda M, Okuda T, Teramoto T, Oguri T, Fujita I, et al. Prevention of growth of a human gastric cancer xenograft in nude mice with anti-EGF receptor antibody. In: Takahashi T, editor. Recent Advances in Management of Digestive Cancers. Tokyo: Springer-Verlag, 1993:403-5.
13. Masui H, Kawamoto T, Sato JD, Wolf B, Sato G, Mendelsohn J. Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res 1984;44:1002-7.
14. Masui H, Moroyama T, Mendelsohn J. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes. Cancer Res 1986;46:5592-8.
15. Rodeck U, Herlyn M, Herlyn D, Molthoff C, Atkinson B, Varello M, et al. Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor: immunologically mediated and effector cell-independent effects. Cancer Res 1987;47:3692-6.
16. Yoshiyuki T, Shimizu Y, Onda M, Tokunaga A, Kiyama T, Nishi K, et al. Immunohistochemical demonstration of epidermal growth factor in human gastric cancer xenografts of nude mice. Cancer 1990;65:953-7.
17. Baselga J, Mendelsohn J. The epidermal growth factor receptor as a target for therapy in breast carcinoma. Breast Cancer Res Treat 1994;29:127-38.
18. Gill GN, Kawamoto T, Cochet C, Le A, Sato JD, Masui H, et al. Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. J Biol Chem 1984;259:7755-60.
19. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
20. Scatchard G. The attractions of proteins for small molecules and ions. Ann N Y Acad Sci 1949;51:600-72.
21. Masui H, Boman B, Hyman J, Castro L, Mendelsohn J, editors. Treatment with anti-EGF receptor monoclonal antibody causes regression of DiFi human colorectal carcinoma xenografts. Proceedings of the 82nd Annual Meeting of the American Association of Cancer Research; May 15-18, 1991; Houston, TX. 32;394.
22. Delellis RA. Does the evaluation of proliferative activity predict malignancy or prognosis in endocrine tumors? Hum Pathol 1995;26:131-4.
23. Darzynkiewicz Z, Traganos F, Melamed MR. New cell cycle compartments identified by multiparameter flow cytometry. Cytometry 1980;1:98-108.
24. Ciardiello F, Damiano V, Bianco C, Isernia GI, Ruggiero A, Caraglia M, et al. Cooperative antiproliferative effects of 8-chloro-cyclic AMP and 528 anti-epidermal growth factor receptor monoclonal antibody on human cancer cells. Clin Cancer Res 1995;1:161-7.
25. Wu X, Fan Z, Masui H, Rosen N, Mendelsohn J. Apoptosis induced by blocking epidermal growth factor receptors is rescued by insulin through insulin-like growth factor I receptor. Proceedings of the 85th Annual Meeting of the American Association of Cancer Research; April 10-13, 1994, San Francisco, CA.
26. Divgi CR, Welt S, Kris M, Real FX, Yea SDJ, Gralla R, et al. Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma. J Natl Cancer Inst 1991;83:97-104.
27. Hirota N, Ueda M, Ozawa S, Abe O, Shimizu N. Suppression of an epidermal growth factor receptor-hyperproducing tumor by an immunotoxin conjugate of gelonin and a monoclonal anti-epidermal growth factor receptor antibody. Cancer Res 1989;49:7106-9.
28. Fan Z, Baselga J, Masui H, Mendelsohn J. Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts. Cancer Res 1993;53:4637-42.
29. Baselga J, Norton L, Masui H, Pandiella A, Coplan K, Miller WH Jr., et al. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J Natl Cancer Inst 1993;85:1327-33.